Country 2 Country 4 Cancer (C2C4C) 2023

The 2023 Country 2 Country 4 Cancer ride organised by Bristol Myers Squibb will feature more than 90 of the company's employees cycling in five European countries from 1-18th September in support of the Union for International Cancer Control (UICC) and selected members to raise funds with the aim of accelerating the fight against cancer and facilitating a better life for cancer patients.

For the 8th year, the 2023 edition of the Country 2 Country 4 Cancer (C2C4C) ride will feature more than 90 BMS employees riding in Germany, Switzerland, France, Spain and the United Kingdom for nearly 3,000 kilometres from 1-18 September.

The total length of the ride is 18 days and will be split into three days per each team. This year is a celebration of 10 years of C2C4C with the inaugural ride taking place in the United States in 2014.

Since 2016, nearly 550 Bristol Myers Squibb employees in Europe have raised more USD2.6 million through the C2C4C ride.

In this 2023 edition, six teams will feature riders participating from 19 countries including Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom, the United States and for the first time, participants from the Czech Republic, Hungary, Poland and Romania. The goal of C2C4C is to raise awareness for cancer research and European cancer organisations who are members of UICC.

Who are the riders

The participants are novice riders who have committed themselves to 5 months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. All are dedicated Bristol Myers Squibb employees who are riding to help raise funds to fight against cancer by supporting European cancer organisations, who are members of UICC.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Why raise funds for cancer organisations

Cancer is among the leading causes of death worldwide. Each year, there are 18.1 million new cases and 9.6 million cancer-related deaths worldwide, and these numbers are growing.

This is why Bristol Myers Squibb has chosen to support the UICC and its members in their mission to reduce the global cancer burden and integrate cancer control into the world health and development agenda.

Encourage your colleagues, families and friends to donate, as cancer affects us all. Each team rides and raises funds for members of the Union for International Cancer Control.

How to support the C2C4C 2022 ride

Click on the charity of your country below to support and donate to a local cancer patient organisation. Donations are open as of 1 June 2023.

Leg	Ride Date	Country Teams	Route	Charity Partner
1	Sept. 1-3 2023	Germany	Munich, Germany to Boudry, Switzerland	Initiative Krebskranke Kinder München e.V.
2	Sept. 4-6 2023	Italy, Switzerland & Austria	Boudry, Switzerland to Nimes, France	Italy: I nitiative Krebskranke Kinder München e.V.
3	Sept. 7-9 2023	Denmark, Finland, Norway & Sweden	Nimes, France to Girona, Espagne	Denmark: SMIL-FondenFinland: Association of Cancer Patients in Finland Norway: AKTIV Mot Kreft Sweden: Barncancerfonden
4	Sept. 10-12 2023	Spain & Portugal	Girona, Espagne to Toulouse, France	Asociación Española Contra el Cáncer
5	Sept. 13-15 2023	France	Toulouse France to Paris	ELLyE
6	Sept. 16-18 2023	UK & Ireland Netherlands & Belgium	Paris, France to Uxbridge, UK	UK-Ireland: Maggie's Cancer Centres and The Irish Cancer Society Netherlands: Villa Joep Belgium: Belgium Foundation Against Cancer
Riders in multiple segments

Quotes

“I continue to be amazed and inspired by our Country 2 Country 4 Cancer ride. Our motto, ‘It’s more than a bike ride,’ has deep meaning to our employees as it truly speaks to the passion and focus of our work. We put the patients at the center of what we do and raising funds to advance cancer research is one of the most powerful and important examples of making a difference for our employees and most especially for patients and their families in need.”

Martin Whalen

General Manager, EU Cluster Markets

“On the 2nd day of the C2C4C ride in 2019, one of our co-riders learned that his wife was just diagnosed with breast cancer. Suddenly, all the efforts with training and fundraising made a lot more sense to all of us. The next day, Emma’s name was on our t-shirts and on top of our minds while climbing the Els Angels towards Girona.”